Optimal trough concentration of voriconazole with therapeutic drug monitoring in children: A systematic review and meta-analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimal trough concentration of voriconazole with therapeutic drug monitoring in children: A systematic review and meta-analysis
Authors
Keywords
Voriconazole, Meta-analysis, Therapeutic drug monitoring, Children
Journal
JOURNAL OF INFECTION AND CHEMOTHERAPY
Volume 27, Issue 2, Pages 151-160
Publisher
Elsevier BV
Online
2020-12-27
DOI
10.1016/j.jiac.2020.11.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients
- (2018) Xiao-bin Lin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Utility of voriconazole therapeutic drug monitoring: a meta-analysis
- (2016) Me-Linh Luong et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
- (2016) Haiying Jin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal Infections
- (2015) Hyun Mi Kang et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch Regimens in Immunocompromised Japanese Pediatric Patients
- (2014) Masaaki Mori et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications
- (2014) Chris Stockmann et al. CLINICAL PHARMACOKINETICS
- Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
- (2013) H. R. Ashbee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
- (2013) Yukihiro Hamada et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Monitoring of voriconazole plasma concentrations in immunocompromised paediatric patients
- (2012) S. Pieper et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis
- (2012) Yukihiro Hamada et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients
- (2012) Alicia Gómez-López et al. MEDICAL MYCOLOGY
- Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis
- (2012) Soo-Han Choi et al. PEDIATRIC BLOOD & CANCER
- Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study
- (2011) P. Soler-Palacin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antifungal prophylaxis in pediatric hematology/oncology: New choices & new data
- (2011) Christopher C. Dvorak et al. PEDIATRIC BLOOD & CANCER
- Therapeutic Drug Monitoring of Voriconazole in Children
- (2011) Jennifer Chen et al. THERAPEUTIC DRUG MONITORING
- Impact of Therapeutic Drug Monitoring of Voriconazole in a Pediatric Population
- (2010) Roger J. M. Brüggemann et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Voriconazole Pharmacokinetics and Pharmacodynamics in Children
- (2009) Michael Neely et al. CLINICAL INFECTIOUS DISEASES
- Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders
- (2009) Koki Ueda et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies
- (2008) M. O. Karlsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers
- (2008) Guo Wang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2C19Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole
- (2008) Johanna Weiss et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now